Advanced search
Publication Cover
International Journal of Neuroscience Volume 123, 2013 - Issue 3
Submit an article Journal homepage
311
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Is 6 Months of Neuroleptic Withdrawal Sufficient to Distinguish Drug-Induced Parkinsonism From Parkinson's Disease?

T. T. LimCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
A. AhmedCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
I. ItinCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
M. GostkowskiCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
J. RudolphCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
,
S. CooperCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USA
&
H. H. FernandezCenter for Neurological Restoration, Cleveland Clinic Foundation, Cleveland, Ohio, USACorrespondence[email protected]
[email protected]
 show all
Pages 170-174 | Received 20 May 2012, Published online: 04 Jan 2013

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matthew Feldman, Sarah Marmol & Jason Margolesky. (2022) Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic. Therapeutics and Clinical Risk Management 18, pages 1129-1142.
Read now

Articles from other publishers (16)

Jessica McClard, Colin McLeod & John C. Morgan. 2023. Mechanisms and Emerging Therapies in Tremor Disorders. Mechanisms and Emerging Therapies in Tremor Disorders527.
José Fidel Baizabal-Carvallo & John C. Morgan. (2022) Drug-induced tremor, clinical features, diagnostic approach and management. Journal of the Neurological Sciences 435, pages 120192.
Crossref
Anastasios Politis, Nikolaos Kokras, Michael Souvatzoglou, Kostas Siarkos, Panagiotis Toulas, Constantin Potagas, Theodoros Hatzipanagiotou, Georgios Limouris & Panagiotis Alexopoulos. (2021) Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series. BMC Psychiatry 21:1.
Crossref
Jan Booij, Marina A. J. Tijssen & Henk W. Berendse. 2021. PET and SPECT in Neurology. PET and SPECT in Neurology 849 870 .
Anett Illés, Péter Balicza, Viktor Molnár, Renáta Bencsik, István Szilvási & Maria Judit Molnar. (2019) Dynamic interaction of genetic risk factors and cocaine abuse in the background of Parkinsonism – a case report. BMC Neurology 19:1.
Crossref
Jaskaren Randhawa & Raja Mehanna. (2019) Drug induced parkinsonism: Symptomatic beyond 22 months. Parkinsonism & Related Disorders 66, pages 267-268.
Crossref
Chien-Hsu Lai, Yi-Chun Yeh & Yen-Yu Chen. (2019) Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism. Therapeutic Advances in Drug Safety 10, pages 204209861985400.
Crossref
Min-Surk Kye, Byung-Kun Kim, Ohyun Kwon, Jong-Moo Park, Jung-Ju Lee, Kyusik Kang, Junghwan Yoon, Namoh Kim & Woong-Woo Lee. (2018) Parkinson’s Disease with Schizophrenia. Journal of the Korean Neurological Association 36:4, pages 384-386.
Crossref
Yoon-Sang Oh, Do-Young Kwon, Joong-Seok Kim, Moon-Ho Park & Daniela Berg. (2018) Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism. Parkinsonism & Related Disorders 46, pages 36-40.
Crossref
Hae-Young Park, Ji-Won Park, Hyun Soon Sohn & Jin-Won Kwon. (2017) Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case–Control Study in South Korea. Drug Safety 40:11, pages 1109-1118.
Crossref
James F. Morley, Gang Cheng, Jacob G. Dubroff, Stephanie Wood, Jayne R. Wilkinson & John E. Duda. (2017) Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism. Movement Disorders Clinical Practice 4:4, pages 603-606.
Crossref
Daniel Tarsy & Raminder Parihar. 2015. Medication-Induced Movement Disorders. Medication-Induced Movement Disorders 61 71 .
Pierre Chue & Bogdan Neagu. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 59 84 .
Jan Booij, Marina A. J. Tijssen & Henk W. Berendse. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology 719 736 .
Raja Mehanna & Hubert H. Fernandez. 2014. Movement Disorders in Dementias. Movement Disorders in Dementias 61 71 .
. (2013) Metoclopramide/risperidone. Reactions Weekly 1448:1, pages 24-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.